Within an overarching theme of generational change in aphasiology, the aims of this paper are to (a) unify the neuroscience of the language impairment of aphasia with the psychosocial science of aphasia, (b) consider the implications of technology and (c) address the global challenge of translational research in this field. To achieve the first two aims, 10 principles of neuroplasticity will be interpreted within the World Health Organization's International Classification of Functioning, Disability and Health (ICF). Two novel treatment approaches to aphasia (UQ Aphasia LIFT and CommFit™) will be described that illustrate how the neuroplasticity principles can be interpreted more broadly within the ICF. The global challenge of translational research will bring the perspective of clinicians and consumers through to aphasia research via 3 recent sets of best practice statements for aphasia. Each demonstrates how the field of aphasiology is undertaking a knowledge synthesis within its broader remit of knowledge transfer and exchange. The Australian Aphasia Rehabilitation Pathway is described as a way of creating living clinical guidelines that are helpful to all stakeholders in aphasia research.

1.
Neuroscience. https://en.wikipedia.org/wiki/Neuroscience (accessed January 2016).
2.
Kleim JA, Jones TA: Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. J Speech Lang Hear Res 2008;51:S225-S239.
3.
Raymer AM, Beeson P, Holland A, Kendall D, Maher LM, Martin N, et al: Translational research in aphasia: from neuroscience to neurorehabilitation. J Speech Lang Hear Res 2008;51:S259-S275.
4.
Johansson BB: Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke 2000;31:223-230.
5.
World Health Organization: International Classification of Functioning, Disability and Health (ICF). Geneva, World Health Organization, 2001.
6.
Ma EP, Worrall L, Threats TT: The International Classification of Functioning, Disability and Health (ICF) in clinical practice. Semin Speech Lang 2007;28:241-243.
7.
Rodriguez AD, Worrall L, Brown K, Grohn B, McKinnon E, Pearson C, et al: Aphasia LIFT: exploratory investigation of an intensive comprehensive therapy programme. Aphasiology 2013;27:1339-1361.
8.
Rose ML, Cherney LR, Worrall LE: Intensive comprehensive aphasia programs: an international survey of practice. Top Stroke Rehabil 2013;20:379-387.
9.
Whyte J, Gordon W, Gonzalez Rothi LJ: A phased developmental approach to neurorehabilitation research: the science of knowledge building. Arch Phys Med Rehabil 2009;90(suppl):S3-S10.
10.
Babbitt E, Worrall L, Cherney L: Clinician perspectives of an intensive comprehensive aphasia program. Top Stroke Rehabil 2013;20:398-408.
11.
Babbitt EM, Worrall L, Cherney LR: Structure, processes, and retrospective outcomes from an intensive comprehensive aphasia program. Am J Speech Lang Pathol 2015;24:S854-S863.
12.
Godecke E, Armstrong E, Hersh D, Ciccone N, Bernhardt J: Learned communicative non-use is a reality in very early aphasia recovery: preliminary results from an ongoing observational study (poster abstract). Clinical Aphasiology Conference, Tucson, 2013.
13.
Vickers CP: Social networks after the onset of aphasia: the impact of aphasia group attendance. Aphasiology 2010;24:902-913.
14.
Brandenburg C, Worrall L, Rodriguez A, Copland D: An exploratory investigation of the daily talk time of people with aphasia: comparison to non-aphasic peers and ICF domains. Under review.
15.
Brandenburg C, Worrall L, Copland D, Power E, Rodriguez AD: The development and accuracy testing of CommFit™, an iPhone application for individuals with aphasia. Aphasiology 2016;30:320-338.
16.
Rodriguez A, Brandenburg C, Worrall L, Power E, Copland D: Using mobile technology to assess and manage communicative participation in aphasia (abstract). Clinical Aphasiology Conference, Monterey, 2015.
17.
Brown K, Worrall LE, Davidson B, Howe T: Living successfully with aphasia: a qualitative meta-analysis of the perspectives of individuals with aphasia, family members, and speech-language pathologists. Int J Speech Lang Pathol 2012;14:141-155.
18.
Flodgren G, Parmelli E, Doumit G, Gattellari M, O'Brien MA, Grimshaw J, Eccles MP: Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2011;8:CD000125.
19.
Kagan A, Simmons-Mackie N, Brenneman Gibson J, Conklin J, Elman RJ: Closing the evidence, research, and practice loop: examples of knowledge transfer and exchange from the field of aphasia. Aphasiology 2009;24:535-548.
20.
Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N: Lost in knowledge translation: time for a map? J Contin Educ Health Prof 2006;26:13-24.
21.
Power E, Thomas E, Worrall L, Rose M, Togher L, Nickels L, et al: Development and validation of Australian aphasia rehabilitation best practice statements using the RAND/UCLA appropriateness method. BMJ Open 2015;5:e007641.
22.
Shrubsole K, Worrall L, Power E, O'Connor D: Recommendations for aphasia rehabilitation: An updated systematic review and evaluation of clinical practice guidelines. Aphasiology, in press.
23.
Simmons-Mackie N, Worrall L, Murray L, Enderby P, Rose M, Paek E, Klippi A; Aphasia United Best Practices Working Group and Advisory Committee: The top ten: best practice recommendations for aphasia. Under review.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.